Cambridge Cognition (LON:COG) Sets New 52-Week Low – Time to Sell?

Shares of Cambridge Cognition Holdings Plc (LON:COG) hit a new 52-week low during mid-day trading on Tuesday. The stock traded as low as GBX 26 and last traded at GBX 27.65, with a volume of 14,910 shares trading hands. The stock had previously closed at GBX 28.

Cambridge Cognition Stock Down 1.3%

The business’s 50 day moving average is GBX 28.51 and its 200 day moving average is GBX 33.93. The company has a quick ratio of 0.96, a current ratio of 0.41 and a debt-to-equity ratio of 10.91. The company has a market cap of £14.93 million, a P/E ratio of -8.92 and a beta of 0.81.

Cambridge Cognition (LON:COG) last announced its earnings results on Wednesday, September 16th. The company reported GBX (1.60) earnings per share (EPS) for the quarter. Cambridge Cognition had a negative net margin of 13.86% and a negative return on equity of 54.17%. As a group, equities analysts anticipate that Cambridge Cognition Holdings Plc will post 1.03 earnings per share for the current fiscal year.

Cambridge Cognition Company Profile

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.